Loading

Get in touch: we're here to assist with your inquiries and support your needs.

Astra Industrial Group announces its Interim Financial results for the Period Ending on 2026-09-30 ( Nine Months )

Element List

Current Quarter

Similar quarter for previous year

%Change

Previous Quarter

% Change

Sales/Revenue

586,122,273

730,058,449

-19.715

775,872,842

-24.456

Gross Profit (Loss)

287,677,113

346,013,712

-16.859

384,226,035

-25.128

Operational Profit (Loss)

144,262,075

182,083,158

-20.771

194,128,148

-25.687

Net Profit (Loss) Attributable to Shareholders of the Issuer

134,710,789

167,442,561

-19.548

192,062,164

-29.86

Total Comprehensive Income Attributable to Shareholders of the Issuer

117,267,438

169,711,204

-30.901

226,525,778

-48.232

All figures are in (Actual) Saudi Arabia, Riyals

Element List

Current Period

Similar period for previous year

%Change

Sales/Revenue

2,152,904,162

2,278,898,920

-5.528

Gross Profit (Loss)

1,057,162,483

1,045,200,698

1.144

Operational Profit (Loss)

530,475,938

574,998,580

-7.743

Net Profit (Loss) Attributable to Shareholders of the Issuer

499,911,762

514,238,096

-2.785

Total Comprehensive Income Attributable to Shareholders of the Issuer

516,308,905

521,230,635

-0.944

Total Shareholders Equity (after Deducting Minority Equity)

3,198,299,587

2,805,036,713

14.019

Profit (Loss) per Share

6.25

6.43

All figures are in (Actual) Saudi Arabia, Riyals

Element List

Amount

Percentage of the capital (%)

Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value

–

–

All figures are in (Actual) Saudi Arabia, Riyals

Element List

Explanation

The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is

Sales decrease in general due to:

Decrease in Sales in the following segments:
1. Pharmaceuticals
2. Steel industries.

The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is

Net profit decreases in general due to:

Decrease in Gross Profit in following segments:
1. Pharmaceuticals.
2. Specialty chemical.

The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is

Sales decrease in general due to:
Decrease in Sales in all Segments.

The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is

Net profit Decreases in general due to:

1. Decrease in Gross Profit in all segments.
2. Decrease in Other income, net in others segment mainly due to accounting treatment related to recognition of other income for Tier 1 sukuk.
While noting that there is decrease in Selling and distribution expenses, General and administrative expenses, and Provision for impairment of financial assets expense.

The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is

Sales decreases in general due to:

Decrease in Sales in the following segments:
1. Steel industries.
2. Specialty chemical.

The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is

Net profit Decreases in general due to:

During similar period last year, there were lower General and administrative expenses in Steel industries segment due to reversal of excess accrual.

Statement of the type of external auditor’s report

Unmodified conclusion

Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)

NA

Reclassification of Comparison Items

NA

Additional Information

Net Shareholders’ Equity at the end of the period was SR 3,197,600,551/- compared to SR 2,826,326,481/- at the end of the similar period last year with an increase of 13%.